Alpha-fetoprotein (AFP) is present in fetal serum in concentrations up to 5,000,000 μg/l. Postnatally AFP gene expression is turned down with a subsequent fall of the serum concentrations to 'adult values' of about 0.5-15 μg/l from the age of 2 years onwards. Individuals with AFP deficiency and those with hereditary persistence of AFP can however be normal. During pregnancy, AFP (in maternal serum) has long been recognized as a marker for congenital anomalies of the fetus. AFP is also a biomarker for hepatocellular carcinoma and some other malignancies.
Increased serum AFP is a biomarker for Ataxia Telangiectasia, ataxia-oculomotor apraxia 2 (AOA2), Deoxyguanosine Kinase Deficiency(DGUOK) deficiency (hepatocerebral form of mtDNA depletion). Measurement of serum AFP is very useful in the diagnostic workup of autosomal recessive cerebellar ataxias (ARCAs).
CSF AFP levels in normal infants also decline with gestational age in proportion to levels of AFP in serum[3][4].